A detailed history of Alpha Dna Investment Management LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 10,323 shares of BSX stock, worth $944,554. This represents 0.33% of its overall portfolio holdings.

Number of Shares
10,323
Previous 10,604 2.65%
Holding current value
$944,554
Previous $816,000 6.0%
% of portfolio
0.33%
Previous 0.33%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$72.96 - $84.0 $20,501 - $23,604
-281 Reduced 2.65%
10,323 $865,000
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $713,967 - $824,036
10,604 New
10,604 $816,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.